![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Leukemia |
Free Subscription
1 Acta Haematol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Leukemia is free of charge.
Single-center experience of patients with plasma cell leukemia in the era of new
therapeutics.
Acta Haematol. 2024 May 19. doi: 10.1159/000539223.
PubMed
Abstract available
Peripheral blood stem cell versus bone marrow graft for patients >/=60 years
undergoing reduced intensity conditioning haploidentical transplantation for
acute myeloid leukemia in complete remission: An analysis of the Acute Leukemia
Working Party of
Am J Hematol. 2024 May 23. doi: 10.1002/ajh.27343.
PubMed
Abstract available
BCR::ABL1 digital PCR for treatment-free remission prediction in chronic myeloid
leukemia patients: An individual participant data meta-analysis.
Am J Hematol. 2024 May 20. doi: 10.1002/ajh.27359.
PubMed
Blinatumomab-induced macrophage activating syndrome (MAS) in adult with B-cell
acute lymphoblastic leukemia (B-ALL).
Ann Hematol. 2024 May 24. doi: 10.1007/s00277-024-05795.
PubMed
Abstract available
Acute myeloid leukemia with paraneoplastic pemphigus successfully treated with a
personalized antileukemic and immunosuppressive strategy.
Ann Hematol. 2024 May 23. doi: 10.1007/s00277-024-05804.
PubMed
Abstract available
Selective eradication of venetoclax-resistant monocytic acute myeloid leukemia
with iron oxide nanozymes.
Biochem Biophys Res Commun. 2024;719:150117.
PubMed
Abstract available
SMACing down relapsed T-ALL.
Blood. 2024;143:2116-2117.
PubMed
CD8+ T-cell Differentiation and Dysfunction Inform Treatment Response in Acute
Myeloid Leukemia.
Blood. 2024 May 22:blood.2023021680. doi: 10.1182/blood.2023021680.
PubMed
Abstract available
Targeting the tumor microenvironment for treating double refractory chronic
lymphocytic leukemia.
Blood. 2024 May 22:blood.2023022861. doi: 10.1182/blood.2023022861.
PubMed
Abstract available
Treatment outcomes of pediatrics acute myeloid leukemia (AML) and associated
factors in the country's tertiary referral hospital, Ethiopia.
BMC Cancer. 2024;24:640.
PubMed
Abstract available
Shorter long-term post-transplant life expectancy may be due to prior
chemotherapy for the underlying disease: analysis of 3012 patients with acute
myeloid leukemia enrolled on 9 consecutive ECOG-ACRIN trials.
Bone Marrow Transplant. 2024 May 22. doi: 10.1038/s41409-024-02308.
PubMed
Abstract available
Allogeneic hematopoietic cell transplantation with sequential conditioning
regimen in relapsed refractory acute myeloid leukemia.
Bone Marrow Transplant. 2024 May 22. doi: 10.1038/s41409-024-02310.
PubMed
Overexposure to venetoclax is associated with prolonged-duration of neutropenia
during venetoclax and azacitidine therapy in Japanese patients with acute myeloid
leukemia.
Cancer Chemother Pharmacol. 2024 May 23. doi: 10.1007/s00280-024-04673.
PubMed
Abstract available
The opportunities and challenges of using PD-1/PD-L1 inhibitors for leukemia
treatment.
Cancer Lett. 2024;593:216969.
PubMed
Abstract available
Anlotinib synergizes with venetoclax to induce mitotic catastrophe in acute
myeloid leukemia.
Cancer Lett. 2024 May 17:216970. doi: 10.1016/j.canlet.2024.216970.
PubMed
Abstract available
Outcomes of patients aged >/=26 years with relapsed or refractory B-cell acute
lymphoblastic leukemia in ZUMA-3 and historical trials.
Leuk Lymphoma. 2024 May 24:1-10. doi: 10.1080/10428194.2024.2353877.
PubMed
Abstract available
Immune escape of B-cell lymphoblastic leukemic cells through a lineage switch to
acute myeloid leukemia.
Leuk Lymphoma. 2024 May 22:1-11. doi: 10.1080/10428194.2024.2351194.
PubMed
Abstract available
Experience in improving treatment outcomes for childhood acute lymphoblastic
leukemia: real-world results for a province in China, 2011-2020.
Leuk Lymphoma. 2024 May 20:1-11. doi: 10.1080/10428194.2024.2350665.
PubMed
Abstract available
Single vs double umbilical cord blood transplantation in acute leukemia:
Systematic review and meta-analysis.
Leuk Res. 2024;142:107517.
PubMed
Abstract available
To Mars and beyond. Space exploration and space medicine in Leukemia.
Leukemia. 2024 May 22. doi: 10.1038/s41375-024-02286.
PubMed
Diagnostic and treatment strategies for pediatric acute lymphoblastic leukemia in
low- and middle-income countries.
Leukemia. 2024 May 18. doi: 10.1038/s41375-024-02277.
PubMed
Abstract available
Combining inotuzumab ozogamicin with PARP inhibitors olaparib and talazoparib
exerts synergistic cytotoxicity in acute lymphoblastic leukemia by inhibiting DNA
strand break repair.
Oncol Rep. 2024;52:90.
PubMed
Abstract available
Impact of aging on acute myeloid leukemia epidemiology and survival outcomes: A
real-world, population-based longitudinal cohort study.
PLoS One. 2024;19:e0300637.
PubMed
Abstract available
Tweaking the NRF2 signaling cascade in human myelogenous leukemia cells by
artificial nano-organelles.
Proc Natl Acad Sci U S A. 2024;121:e2219470121.
PubMed
Abstract available
Thank you for your interest in scientific medicine.